7/13/2018 9:49 AM
Shares of Advaxis, Inc. (NASDAQ:ADXS) are surging, after the U.S. Food and Drug Administration (FDA) lifted its clinical hold on a trial for the company's cervical cancer drug, axalimogene filolisbac...
3/6/2017 10:55 AM
Biotech stocks are among the big movers this morning, even as expectations for a March interest-rate hike weigh on the broader market. Three names gaining ground are Advaxis, Inc. (NASDAQ:ADXS), Nov...
6/30/2015 11:33 AM
By now, traders are accustomed to seeing big moves from biotech stocks, in either direction. Today, many biotechs are moving to the upside, which is apparent when looking at the top of the Nasdaq Com...